VEGFR2/CD309 anticorps

N° du produit ABIN643552

Cet anticorps Lapin Polyclonal détecte spécifiquement VEGFR2/CD309 dans IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour VEGFR2/CD309 anticorps (ABIN643552)

Antigène: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VEGFR2/CD309 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-VEGFR2/CD309 anticorps

Fonction: Rabbit Anti-Human VEGFR2

Specificité: DS-PB-02108 detects vascular endothelial growth factor receptor 2 (VEGFR2), a member of the tyrosine kinase family that plays an essential role in transducing the major signals for angiogenesis. VEGFR2 has also been implicated in embryonic development, wound healing, cell proliferation, migration and differentiation. VEGFR2 is expressed mostly on vascular endothelial cells, and is expressed on a subpopulation of haematopoietic cells which might be the progenitor for endothelial cells. Mutated forms of VEGFR2 have been implicated in cancer and diabetic retinopathy, where it results in pathological angiogenesis.

Attributs du produit: Cytokines/Chemokines/Growth Factors/Receptors

Purification: Purified

Immunogène: Antisera to human VEGF receptor 2 were raised by repeated immunisations of rabbits with highly purified antigen. Purified IgG prepared by affinity chromatography.

Isotype: IgG

Information d'application

Indications d'application: Immunohistology - Paraffin

Restrictions: For Research Use only

Stockage

Concentration: IgG concentration 0.5 mg/ml

Buffer: Phosphate buffered saline pH7.7

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur VEGFR2/CD309

Antigène: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Autre désignation: Vascular Endothelial Growth Factor Receptor 2 (VEGF R2)

Pathways: Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling